Biomarker study for colorectal cancer spread
Part of Cancer, Digestive system clinical trials.
This study looks for biological markers that can help predict where colorectal cancer might spread. It aims to find patterns that could guide future treatment decisions. By understanding these markers, doctors may be able to detect and manage cancer recurrence earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have colorectal cancer, or it has come back or spread to other organs like the liver, lungs, or bones.
- You have not had surgery or other cancer treatments yet for this condition.
- You are willing to provide a sample for biomarker testing.
- You do not have other cancers (except the ones listed in the criteria).
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for blood/tumor signals (“biomarkers”) that may help predict outcomes in people whose colorectal cancer returns and spreads after surgery. It mainly helps researchers understand who may do better or worse, which can guide future care.
This study focuses on people with colon cancer (CRC) that has spread to the liver. It looks at factors that may affect liver metastases and could help doctors better understand who may benefit from future treatments.
This study looks at metabolic biomarkers in blood and tumor tissue to help detect colorectal cancer earlier, predict outcomes, and monitor for recurrence. It includes both people newly diagnosed with colorectal cancer and healthy volunteers for comparison.
This study looks at whether a combination of clinical factors and genetic tests can better predict early return of cancer in people who had surgery for colorectal cancer that spread to the liver. It may help guide future treatment decisions.
This study looks at how certain blood markers (nucleosome and CTCF) clear from the body in people with colorectal cancer that has spread to the lining of the belly. It also includes people with other conditions to compare. The goal is to learn more about these markers to help guide treatment.
This study looks at gut bacteria in people with colorectal cancer that has spread (metastatic). It aims to find patterns in the bacteria that may help doctors choose better treatments.
Hear when a new Metastatic Colorectal Cancer (CRC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.